INDBInternet News Database 2.5 Updated just now · 414 sources Show or hide images Light or dark

We're raising our price target on Eli Lilly as the obesity-drug boom rolls on

1 source1 article First seen Updated United States

Save Compare coverage

Summary

We're raising our price target on Eli Lilly as the obesity-drug boom rolls on CNBC Lilly breaks down Medicare Bridge boon as GLP-1 sales drive another guidance lift Fierce Pharma Eli Lilly Stock Jumps on Monster Earnings as Finance Chief Eyes Next Growth Engine Barron's Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters Earnings live updates: Eli Lilly stock pops as strong GLP-1 drug demand lifts results, ServiceNow stock plunges Yahoo Finance

Description from Google News.

Who is covering this

  1. Google News Center Factuality: High US
    We're raising our price target on Eli Lilly as the obesity-drug boom rolls on - CNBC

    We're raising our price target on Eli Lilly as the obesity-drug boom rolls on CNBC Lilly breaks down Medicare Bridge boon as GLP-1 sales drive another guidance lift Fierce Pharma Eli Lilly Stock Jumps on Monster Earnings as Finance Chief Eyes Next Growth Engine Barron's Eli...

Related stories